{"tid":2322877,"cid":5,"subCid":10,"title":"【歐洲好大，歐洲邊度？】食衞局稱復星BioNTech疫苗將於歐洲生產","createTime":"2020-12-12T16:38:40.000Z","updateTime":"2020-12-12T16:45:10.000Z","uid":79563,"like":0,"dislike":1,"uniUserReply":2,"replies":[{"pid":"618e7cc71735500982bfa06b05200f80e2b44032","tid":2322877,"uid":79563,"like":0,"dislike":0,"score":0,"citedBy":0,"replyTime":"2020-12-12T16:38:40.000Z","msg":"<a href=\"https://news.rthk.hk/rthk/ch/component/k2/1564993-20201213.htm?spTabChangeable=0\" data-sr-url=\"https://r.lihkg.com/link?u=https%3A%2F%2Fnews.rthk.hk%2Frthk%2Fch%2Fcomponent%2Fk2%2F1564993-20201213.htm%3FspTabChangeable%3D0&d=Lu%2FYWbP3Pl%2BxzjQ0by0jct%2FsvSzfkBtT%2Fd%2Bxj92WHuQ%3D&h=5dbbf694\" data-ef-url=\"https://embed.lih.kg/frame?u=https%3A%2F%2Fnews.rthk.hk%2Frthk%2Fch%2Fcomponent%2Fk2%2F1564993-20201213.htm%3FspTabChangeable%3D0&h=d07af42a\" target=\"_blank\">https://news.rthk.hk/rthk/ch/component/k2/1564993-20201213.htm?spTabChangeable=0</a><br />\n<br />\n食物及衞生局表示，政府與復星醫藥達成協議，將會取得最多750萬劑由復星與德國藥廠BioNTech合作研發的疫苗，供港的疫苗將於歐洲生產，首批100萬劑量預計最快可於明年第一季交付。<br />\n<br />\n發言人說，根據協議約定，復星醫藥將負責推進疫苗在中國的臨床試驗、上市申請和市場銷售；BioNTech將負責提供區域內臨床試驗申請所需的技術材料和臨床前研究資料、配合區域內臨床試驗，並供應有關臨床試驗及市場銷售所需的產品。<br />\n<br />\n發言人提及，輝瑞是德國BioNTech疫苗中國以外區域的合作夥伴。<br />\n<br />\n發言人又指，另一款由科興控股提供的疫苗在北京大興區生產，首批100萬劑量最快可望於明年一月到港。<br />\n<br />\n特區政府亦將會購入750萬劑由阿斯利康及牛津大學合作研發的疫苗，預計最快可於明年第2季尾分批運抵本港，但基於保密協議，現階段未能公布有關疫苗的生產地的資料。"},{"pid":"c320a75d9814e2941f800195b40f7af11b68a5e6","tid":2322877,"uid":271516,"like":0,"dislike":1,"score":-1,"citedBy":0,"replyTime":"2020-12-12T16:45:10.000Z","msg":"特首打果支同普通市民打果支係咪一樣先"}]}